Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Klein, J.
Right arrow Articles by Lustbader, J.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klein, J.
Right arrow Articles by Lustbader, J.W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 18, No. 1, 50-56, January 2003
© 2003 European Society of Human Reproduction and Embryology

Development and characterization of a long-acting recombinant hFSH agonist

J. Klein1, L. Lobel1, S. Pollak1, B. Lustbader1, R.T. Ogden3, M.V. Sauer1,2 and J.W. Lustbader1,2,4

1 Department of Obstetrics and Gynecology and 2 Center for Reproductive Sciences and 3 Department of Biostatistics, School of Public Health, Columbia University, New York, NY 10032, USA 4 To whom correspondence should be addressed. e-mail: jwl2{at}columbia.edu

BACKGROUND: Fusion of the carboxyterminal peptide (CTP) of hCG to FSH results in a follitropin agonist with an extended half-life, presumably due to the four O-oligosaccharides on the CTP. Alternatively, an rhFSH analogue containing additional N-linked carbohydrate is described in this report. METHODS: A DNA sequence containing two N-oligosaccharide signal sequences was ligated into a vector containing hFSHß- and {alpha}-subunit encoding cDNA, and expressed in CHO-K1 cells. In-vitro bioactivity of the single-chain hormone was assessed in CHO cells expressing the hFSH receptor. Pharmacokinetic values were derived from serial serum assays of the analogue in immature female rats following a single i.v. injection. In-vivo bioactivity was assessed by measuring ovarian weight gain 3 days post-injection. RESULTS: rhFSH-N2 and native rhFSH induced comparable levels of cAMP in vitro. t1/2 for native rhFSH, rhFSH-CTP and rhFSH-N2 were 3.7, 7.1 and 7.3 h respectively. Rats receiving rhFSH-N2 had a mean ± SD ovarian weight 3 days post-i.v. injection (22 ± 3.6 mg) significantly greater than rats receiving rhFSH and saline (16.7 ± 1.5 and 15.3 ± 0.47 mg respectively, P < 0.05). CONCLUSIONS: rhFSH-N2 has prolonged half-life and increased bioactivity compared with native rhFSH. This rhFSH agonist, and other analogues containing additional N-oligosaccharides may have important clinical applications.

Key words: carboxyterminal peptide/FSH/hormone analogue/oligosaccharide/pharmacokinetics


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
The Corifollitropin Alfa Dose-finding Study Group
A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation
Hum. Reprod., August 6, 2008; (2008) den288v1.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Fares, S. Ganem, T. Hajouj, and E. Agai
Development of a Long-Acting Erythropoietin by Fusing the Carboxyl-Terminal Peptide of Human Chorionic Gonadotropin {beta}-Subunit to the Coding Sequence of Human Erythropoietin
Endocrinology, October 1, 2007; 148(10): 5081 - 5087.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. K. Trousdale, S. V. Pollak, J. Klein, L. Lobel, Y. Funahashi, N. Feirt, and J. W. Lustbader
Single-Chain Bifunctional Vascular Endothelial Growth Factor (VEGF)-Follicle-Stimulating Hormone (FSH)-C-Terminal Peptide (CTP) Is Superior to the Combination Therapy of Recombinant VEGF plus FSH-CTP in Stimulating Angiogenesis during Ovarian Folliculogenesis
Endocrinology, March 1, 2007; 148(3): 1296 - 1305.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
H. Ko, W. Park, D.-J. Kim, M. Kobayashi, and Y. C. Sohn
Biological activities of recombinant Manchurian trout FSH and LH: their receptor specificity, steroidogenic and vitellogenic potencies
J. Mol. Endocrinol., January 1, 2007; 38(1): 99 - 111.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I. E. Messinis
Ovulation induction: a mini review
Hum. Reprod., October 1, 2005; 20(10): 2688 - 2697.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S.C. Low, S.L. Nunes, A.J. Bitonti, and J.A. Dumont
Oral and pulmonary delivery of FSH-Fc fusion proteins via neonatal Fc receptor-mediated transcytosis
Hum. Reprod., July 1, 2005; 20(7): 1805 - 1813.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Weenen, J. E. Pena, S. V. Pollak, J. Klein, L. Lobel, R. K. Trousdale, S. Palmer, E. G. Lustbader, R. T. Ogden, and J. W. Lustbader
Long-Acting Follicle-Stimulating Hormone Analogs Containing N-Linked Glycosylation Exhibited Increased Bioactivity Compared with O-Linked Analogs in Female Rats
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5204 - 5212.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Devroey, B. C. Fauser, P. Platteau, N. G. Beckers, M. Dhont, and B. M. Mannaerts
Induction of Multiple Follicular Development by a Single Dose of Long-Acting Recombinant Follicle-Stimulating Hormone (FSH-CTP, Corifollitropin Alfa) for Controlled Ovarian Stimulation before in Vitro Fertilization
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2062 - 2070.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.